AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35979802 — intervention group
Group type: COMPARATOR
Intervention: Standard mass closure
Number of subjects: 802
Study 35979802 — intervention group
Group type: EXPERIMENTAL
Intervention: Hughes closure
Number of subjects: 802
Study 36326668 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 891
Study 36326668 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 891
Study 33398511 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer interval group (> 10 weeks)
Number of subjects: 910
Study 33398511 — intervention group
Group type: COMPARATOR
Intervention: Shorter interval group (≤ 10 weeks)
Number of subjects: 910
Study 33398511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox multivariate regression analysis
Number of subjects: 910
Study 32957394 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative fluid management strategy
Number of subjects: 956
Study 32957394 — intervention group
Group type: COMPARATOR
Intervention: Liberal fluid management strategy
Number of subjects: 956
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet hands
Number of subjects: 122
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry hands
Number of subjects: 122
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreen hands
Number of subjects: 122
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (across all conditions)
Number of subjects: 122
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 122
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 122
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure of contact
Number of subjects: 122
Study 32994540 — intervention group
Group type: EXPERIMENTAL
Intervention: Average adhered sand grain size and average ambient sand grain size
Number of subjects: 122
Study 32506859 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey mouthwash 12.5%
Number of subjects: 60
Study 32506859 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine solution 0.2%
Number of subjects: 60
Study 36450107 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08% nanoemulsion cyclosporine A (TJO‐087) once daily
Number of subjects: 178
Study 36450107 — intervention group
Group type: COMPARATOR
Intervention: 0.05% emulsion cyclosporine A (CsA0.05%) twice daily
Number of subjects: 178
Study 34181564 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training (2 × 4 × 200-m)
Number of subjects: 19
Study 34181564 — intervention group
Group type: COMPARATOR
Intervention: Race-pace continuous workout (600-m)
Number of subjects: 19
Study 34181564 — intervention group
Group type: EXPERIMENTAL
Intervention: Both workouts
Number of subjects: 19
Study 34181564 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training
Number of subjects: 19
Study 33290405 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity duration <5 years
Number of subjects: 20746
Study 33290405 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity duration 20 to 30 years
Number of subjects: 20746
Study 33290405 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity duration
Number of subjects: 20746
Study 34739064 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal screening (all students completed the Patient Health Questionnaire‐9 (PHQ‐9))
Number of subjects: 12909
Study 34739064 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal screening
Number of subjects: 12909
Study 34739064 — intervention group
Group type: COMPARATOR
Intervention: Targeted screening
Number of subjects: 12909
Study 32078064 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium and coenzyme Q10 supplementation
Number of subjects: 308
Study 32576559 — intervention group
Group type: EXPERIMENTAL
Intervention: SSc-ILD
Number of subjects: 86
Study 32576559 — intervention group
Group type: COMPARATOR
Intervention: IPF
Number of subjects: 86
Study 35312782 — intervention group
Group type: EXPERIMENTAL
Intervention: Open harvesting
Number of subjects: 183
Study 35312782 — intervention group
Group type: EXPERIMENTAL
Intervention: External stenting in open-harvest group
Number of subjects: 183
Study 35312782 — intervention group
Group type: EXPERIMENTAL
Intervention: External stenting in endoscopic-harvest group
Number of subjects: 183
Study 32300654 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement protocols to reveal many-body topological invariants using local random unitary operations and site-resolved projective measurements.
Number of subjects: 0
Study 35550262 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg twice per day for 7 days)
Number of subjects: 460
Study 35550262 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin (single 1-g dose)
Number of subjects: 460
Study 35550262 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 460
Study 35550262 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 460
Study 33435831 — intervention group
Group type: COMPARATOR
Intervention: CIT (Conventional Constraint-Induced Therapy)
Number of subjects: 18
Study 33435831 — intervention group
Group type: EXPERIMENTAL
Intervention: CIT-Wii (Wii-augmented Constraint-Induced Therapy)
Number of subjects: 18
Study 33445196 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) applied around the esophageal stoma during total laryngectomy
Number of subjects: 20
Study 33445196 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRF application)
Number of subjects: 20
Study 33319645 — intervention group
Group type: EXPERIMENTAL
Intervention: Arabinoxylan-oligosaccharides (AXOS) 10.4 g/d
Number of subjects: 29
Study 33319645 — intervention group
Group type: COMPARATOR
Intervention: Polyunsaturated fatty acids (PUFA) 3.6 g/d
Number of subjects: 29
Study 32186048 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication (amlodipine 5 mg once daily)
Number of subjects: 80
Study 32186048 — intervention group
Group type: COMPARATOR
Intervention: Medication only (amlodipine 5 mg once daily)
Number of subjects: 80
Study 35997173 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% A. annua extract (AAE)
Number of subjects: 90
Study 35997173 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 90
Study 33975741 — intervention group
Group type: EXPERIMENTAL
Intervention: Flash Glucose Monitoring (FGM)
Number of subjects: 40
Study 33975741 — intervention group
Group type: COMPARATOR
Intervention: Self‐monitoring of blood glucose (SMBG)
Number of subjects: 40
Study 33975741 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FG and CG)
Number of subjects: 40
Study 32739548 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol with respiratory prehabilitation (incentive spirometry)
Number of subjects: 58
Study 32739548 — intervention group
Group type: COMPARATOR
Intervention: Conventional perioperative care
Number of subjects: 58
Study 35627640 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest resistance and expansion exercises (12-week program, 3 sessions per week)
Number of subjects: 32
Study 35627640 — intervention group
Group type: COMPARATOR
Intervention: Usual chest physiotherapy program (control group)
Number of subjects: 32
Study 34246825 — intervention group
Group type: EXPERIMENTAL
Intervention: CollaStat
Number of subjects: 78
Study 34246825 — intervention group
Group type: COMPARATOR
Intervention: Floseal
Number of subjects: 78
Study 33567193 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 548
Study 33567193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 548
Study 32593717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aging Back Clinics (ABCs)
Number of subjects: 330
Study 32593717 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 330
Study 32964434 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-esterified fatty acids (NEFAs)
Number of subjects: 4710
Study 35612859 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (self-selection cohort)
Number of subjects: 1604
Study 35612859 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics (randomized cohort)
Number of subjects: 1604
Study 35612859 — intervention group
Group type: EXPERIMENTAL
Intervention: Appendectomy (self-selection cohort)
Number of subjects: 1604
Study 35612859 — intervention group
Group type: COMPARATOR
Intervention: Appendectomy (randomized cohort)
Number of subjects: 1604
Study 33682286 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics models based on automatic segmentation on ADC maps
Number of subjects: 176
Study 33682286 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics models based on manual segmentation on ADC maps
Number of subjects: 176
Study 33682286 — intervention group
Group type: COMPARATOR
Intervention: Biopsy
Number of subjects: 176
Study 33682286 — intervention group
Group type: COMPARATOR
Intervention: PI-RADS assessment
Number of subjects: 176
Study 32698903 — intervention group
Group type: EXPERIMENTAL
Intervention: Single beta‐conglycinin intake
Number of subjects: 22
Study 32698903 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐conglycinin intake (2 weeks)
Number of subjects: 22
Study 32698903 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (control)
Number of subjects: 22
Study 34581266 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning‐Centered Psychotherapy and Essential Care (MCP‐EC)
Number of subjects: 30
Study 34581266 — intervention group
Group type: COMPARATOR
Intervention: Usual psychological supportive intervention
Number of subjects: 30
Study 33597488 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with malaria treatment and prevention measures
Number of subjects: 360
Study 33597488 — intervention group
Group type: EXPERIMENTAL
Intervention: High-income households
Number of subjects: 360
Study 33597488 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-income households
Number of subjects: 360
Study 35394710 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐CTG
Number of subjects: 42
Study 35394710 — intervention group
Group type: COMPARATOR
Intervention: SCAF
Number of subjects: 42
Study 34517878 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 226
Study 34517878 — intervention group
Group type: COMPARATOR
Intervention: Walking exercises (Control)
Number of subjects: 226
Study 36059099 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cTBS
Number of subjects: 32
Study 36059099 — intervention group
Group type: COMPARATOR
Intervention: Sham cTBS
Number of subjects: 32
Study 34520506 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium (group R)
Number of subjects: 40
Study 34520506 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 40
Study 34520506 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (group B)
Number of subjects: 40
Study 34520506 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group D)
Number of subjects: 40
Study 36427515 — intervention group
Group type: EXPERIMENTAL
Intervention: eMBCT (online mindfulness-based cognitive therapy) for 12 weeks
Number of subjects: 99
Study 36427515 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study 36427515 — intervention group
Group type: EXPERIMENTAL
Intervention: eMBCT
Number of subjects: 99
Study 33168966 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly(adenosine diphosphate [ADP]‐ribose) polymerase inhibitors (PARPi) for patients with homologous recombination repair (HRR) gene mutations
Number of subjects: 0
Study 33168966 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel androgen receptor (AR) degraders
Number of subjects: 0
Study 33168966 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioligand therapy (RLT) with Lu‐PSMA‐617 (Lu‐PSMA)
Number of subjects: 0
Study 33168966 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune‐directed therapies (including PD-1 inhibition, BiTE technology, CAR T-cell therapy)
Number of subjects: 0
Study 33168966 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapies targeting the PI3K‐Akt‐mTOR pathway and EZH2
Number of subjects: 0
Study 32469838 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation (2 mA, 20 min, anodal left‐ cathodal right DLPFC)
Number of subjects: 32
Study 32469838 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study 36099170 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load resistance training with blood flow restriction (LLRT-BFR)
Number of subjects: 46
Study 36099170 — intervention group
Group type: COMPARATOR
Intervention: Low-load resistance training with sham-BFR
Number of subjects: 46
Study 33511544 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaparotomy
Number of subjects: 181
Study 33511544 — intervention group
Group type: COMPARATOR
Intervention: Primary laparotomy
Number of subjects: 181
Study 32358398 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye-acupuncture combined with routine treatment
Number of subjects: 360
Study 32358398 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 360
Study 35484580 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 0
Study 35484580 — intervention group
Group type: COMPARATOR
Intervention: GLP-1RA
Number of subjects: 0
Study 34704393 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 0
Study 32507863 — intervention group
Group type: EXPERIMENTAL
Intervention: SD plus systemic MOX (400 mg QD for 7 days)
Number of subjects: 36
Study 32507863 — intervention group
Group type: EXPERIMENTAL
Intervention: SD plus systemic AMOX+ME (500 mg TID each for 7 days)
Number of subjects: 36
Study 32507863 — intervention group
Group type: COMPARATOR
Intervention: SD plus placebo
Number of subjects: 36
Study 35237339 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI+MRM
Number of subjects: 96
Study 35237339 — intervention group
Group type: COMPARATOR
Intervention: MRI
Number of subjects: 96
Study 33115760 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg
Number of subjects: 3834
Study 33115760 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 30 mg
Number of subjects: 3834
Study 33115760 — intervention group
Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 3834
Study 33115760 — intervention group
Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 3834
Study 33115760 — intervention group
Group type: EXPERIMENTAL
Intervention: upadacitinib 15 mg and 30 mg
Number of subjects: 3834
Study 33115760 — intervention group
Group type: COMPARATOR
Intervention: methotrexate and adalimumab
Number of subjects: 3834
Study 32410265 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 15
Study 32410265 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 15
Study 32410265 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 15
Study 35078009 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical (MIS) radical hysterectomy (RH)
Number of subjects: 5575
Study 34508654 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab (0.0128-60 mg)
Number of subjects: 73
Study 34508654 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab (48 mg)
Number of subjects: 73
Study 34508654 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab (0.76-48 mg)
Number of subjects: 73
Study 34508654 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epcoritamab
Number of subjects: 73
Study 32407973 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treadmill exercise after ICH (ICH + ET)
Number of subjects: 4
Study 32407973 — intervention group
Group type: COMPARATOR
Intervention: No training after ICH (ICH)
Number of subjects: 4
Study 32407973 — intervention group
Group type: COMPARATOR
Intervention: Late treadmill exercise after ICH (ICH + LT)
Number of subjects: 4
Study 35968375 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ISF-NF training
Number of subjects: 22
Study 35968375 — intervention group
Group type: COMPARATOR
Intervention: Sham ISF-NF training
Number of subjects: 22
Study 35170383 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative theatre visit with an informative session regarding the surgery
Number of subjects: 64
Study 35170383 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative theatre visit)
Number of subjects: 64
Study 33950550 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use disorder (CUD)
Number of subjects: 161405
Study 33353965 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 diabetes (T1D)
Number of subjects: 23
Study 33353965 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study 35292232 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Evaluation and Management‐Survivorship (GEMS) intervention
Number of subjects: 780
Study 32224723 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric anesthesiology fellowship training
Number of subjects: 202
Study 32224723 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthesiology residency training
Number of subjects: 202
Study 32224723 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender diversity in pediatric anesthesiology fellowship programs
Number of subjects: 202
Study 35647963 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolve Pure™ Eyewipes twice a day along with standard therapy (antibiotic and lubricants)
Number of subjects: 50
Study 35647963 — intervention group
Group type: COMPARATOR
Intervention: Warm compresses along with standard therapy
Number of subjects: 50
Study 34371004 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 0
Study 34371004 — intervention group
Group type: COMPARATOR
Intervention: Sodium thiosulfate (STS)
Number of subjects: 0
Study 33143987 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-facilitated Screening and Brief Intervention (cSBI) system
Number of subjects: 54
Study 33143987 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 54
Study 32902075 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraction sockets filled with bovine bone mineral and membrane with EMD (test group 1)
Number of subjects: 28
Study 32902075 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraction sockets filled with bovine bone mineral and membrane without EMD (test group 2)
Number of subjects: 28
Study 32902075 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous healing (control group)
Number of subjects: 28
Study 32902075 — intervention group
Group type: EXPERIMENTAL
Intervention: Test groups 1 and 2 (with and without EMD)
Number of subjects: 28
Study 35925809 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine integrated into opioid treatment programs (OTPs)
Number of subjects: 344
Study 35925809 — intervention group
Group type: COMPARATOR
Intervention: Offsite referral
Number of subjects: 344
Study 35841489 — intervention group
Group type: EXPERIMENTAL
Intervention: RTCP + UC
Number of subjects: 108
Study 35841489 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 108
Study 33560891 — intervention group
Group type: EXPERIMENTAL
Intervention: MT-1207 (5-40 mg)
Number of subjects: 56
Study 33560891 — intervention group
Group type: EXPERIMENTAL
Intervention: MT-1207 (40 mg) with food
Number of subjects: 56
Study 33560891 — intervention group
Group type: EXPERIMENTAL
Intervention: MT-1207 (5-20 mg)
Number of subjects: 56
Study 33560891 — intervention group
Group type: EXPERIMENTAL
Intervention: MT-1207
Number of subjects: 56
Study 34266340 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized ruler for preoperative marking (Group 2)
Number of subjects: 42
Study 34266340 — intervention group
Group type: COMPARATOR
Intervention: Classic technique for preoperative marking (Group 1)
Number of subjects: 42
Study 33982896 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac-Hyaluronate Conjugate
Number of subjects: 1
Study 33982896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 36099269 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (APAP) use during pregnancy
Number of subjects: 232
Study 34902299 — intervention group
Group type: EXPERIMENTAL
Intervention: Frail White male SP
Number of subjects: 855
Study 34902299 — intervention group
Group type: EXPERIMENTAL
Intervention: Frail Black male SP
Number of subjects: 855
Study 34902299 — intervention group
Group type: COMPARATOR
Intervention: Vigorous male SP
Number of subjects: 855
Study 34902299 — intervention group
Group type: COMPARATOR
Intervention: Ratings by male workers
Number of subjects: 855
Study 32617960 — intervention group
Group type: EXPERIMENTAL
Intervention: DAV132 (10 dose regimens)
Number of subjects: 143
Study 32617960 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin only
Number of subjects: 143
Study 32617960 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study 33421045 — intervention group
Group type: EXPERIMENTAL
Intervention: Black mulberry syrup gargling (5 ml, 3 times a day for 15 days)
Number of subjects: 40
Study 33421045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 40
Study 34459400 — intervention group
Group type: EXPERIMENTAL
Intervention: Apabetalone
Number of subjects: 464
Study 34459400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study 32619792 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy New Nordic Diet (NND)
Number of subjects: 142
Study 32619792 — intervention group
Group type: COMPARATOR
Intervention: Average Danish Diet (ADD)
Number of subjects: 142
Study 34748169 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine calcium and vitamin D supplementation (group B)
Number of subjects: 203
Study 34748169 — intervention group
Group type: COMPARATOR
Intervention: Calcium and vitamin D supplementation exclusively to symptomatic patients (group A)
Number of subjects: 203
Study 32878424 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight vest technical‐tactical training (WTG)
Number of subjects: 15
Study 32878424 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight vest plyometric training (WPG)
Number of subjects: 15
Study 32878424 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 15
Study 32878424 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups (WPG, WTG, CG)
Number of subjects: 15